CoChat

Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

Taussig, David C., Miraki-Moud, Farideh, Anjos-Afonso, Fernando, Pearce, Daniel J., Allen, Kirsty, Ridler, Christopher, Lillington, Debra, Oakervee, Heather, Cavenagh, Jamie, Agrawal, Samir G., Lister, T. Andrew, Gribben, John G., Bonnet, Dominique · 2008 · Blood

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Immunodeficient mice are increasingly used to assay human hematopoietic repopulating cells as well as leukemia-initiating cells. One method commonly used to isolate these rare cells is to sort cells stained with fluorochrome-conjugated antibodies into fractions, then transplant the different fractions into immunodeficient mice to test their repopulating ability. The antibodies are generally treated as being neutral in terms of their effects on the experiment. Human repopulating cells are thought to express CD34 and lack CD38. Here we present evidence that anti-CD38 antibodies have a profound inhibitory effect on engraftment of cord blood and leukemia cells. We show that this effect is Fc-mediated and can be overcome by treating mice with immunosuppressive antibodies. When this inhibitory effect is prevented, we demonstrate that the CD34+CD38+ fraction of certain acute myeloid leukemia samples contains all, or at least most, leukemia-initiating cell capacity. This study highlights the potential pitfall of antibody-mediated clearance of repopulating cells and is important for any groups working with this model. More importantly, the work suggests that there is greater variation in the phenotypes of leukemia-initiating cells than previously suggested.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2007-10-118331

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 395

Metadata

Authors
Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., Lister, T. A., Gribben, J. G., & Bonnet, D.
Affiliations
  • St Bartholomew's Hospital (GB)
  • Department of Medical Oncology, St Bartholomew's Hospital, London; and
  • Haematopoietic Stem Cell Laboratory and
  • Cancer Research UK (GB)
Venue
Blood
Published
2008-08-01
Volume
112
Issue
3
Pages
568-575
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1988397531
Cited by
373
References
25
Citations by year
2026: 2 · 2025: 6 · 2024: 11 · 2023: 14 · 2022: 12 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 12 · 2017: 20 · 2016: 21 · 2015: 29 · 2014: 28 · 2013: 34 · 2012: 42
FWCI
20.05
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
Funders
Cancer Research UK
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords
anti-CD38 monoclonal antibody, leukemia-initiating cells, CD34, CD38, acute myeloid leukemia, immunodeficient mice, cellular heterogeneity
MeSH terms
Animals, Antibodies, Cells, Cultured, Fetal Blood, Graft Survival, Humans, Neoplasm Transplantation, Leukemia, Myeloid, Acute, Mice, SCID, Antigens, CD34, Cord Blood Stem Cell Transplantation, Mice, ADP-ribosyl Cyclase 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. https://app.cochat.ai/papers/10.1182/blood-2007-10-118331
The paper
Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., Lister, T. A., Gribben, J. G., & Bonnet, D. (2008). Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. https://doi.org/10.1182/blood-2007-10-118331

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.